DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Schmid P, Cortes J, Dent R. et al
KEYNOTE-522: Phase 3 Study of Pembrolizumab + Chemotherapy versus Placebo + Chemotherapy as Neoadjuvant Treatment, Followed by Pembrolizumab versus Placebo as Adjuvant Treatment for Early Triple-Negative Breast Cancer (TNBC).
Ann Oncol 2019;
30 (Suppl. 05) v851-v934 . doi:10.1093/annonc/mdz1394
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.